» Articles » PMID: 25211867

Recommended Solutions to the Barriers to Immunization in Children and Adults

Overview
Journal Mo Med
Specialty General Medicine
Date 2014 Sep 13
PMID 25211867
Citations 55
Authors
Affiliations
Soon will be listed here.
Abstract

Vaccines prevent disease and mortality. They are the foremost achievement of public health programs in the United States and internationally. In the early 90s the National Vaccine Advisory Committee concluded that there were significant barriers to young children being fully immunized including inconvenient and limited clinic hours for immunization, inadequate access to health care, and vaccine administration fees. Barriers to adult immunization also have been identified. This article will discuss research addressing barriers to immunization and possible solutions.

Citing Articles

Expanding vaccination provider types and administration sites can increase vaccination uptake: A systematic literature review of the evidence in non-United States geographies.

Larson A, Shanmugam P, Mitrovich R, Vohra D, Lansdale A, Eiden A Hum Vaccin Immunother. 2025; 21(1):2463732.

PMID: 40025682 PMC: 11881856. DOI: 10.1080/21645515.2025.2463732.


Pharmacists as Partners in Pediatric Immunizations: A White Paper From the Pediatric Pharmacy Association.

Girotto J, Klein K, Cober M, Cavness A, Hagemann T, Warminski S J Pediatr Pharmacol Ther. 2024; 29(6):660-666.

PMID: 39659850 PMC: 11627576. DOI: 10.5863/1551-6776-29.6.660.


Service delivery in postpandemic period for routine childhood immunization in Assam following capacity building with BRIDGE IPC Skill tool.

Mahanta T, Nirmolia N, Biswas A, Barua S J Family Med Prim Care. 2024; 13(10):4482-4485.

PMID: 39629361 PMC: 11610840. DOI: 10.4103/jfmpc.jfmpc_1899_23.


Risk of COVID-19 in Children throughout the Pandemic and the Role of Vaccination: A Narrative Review.

Weber D, Zimmerman K, Tartof S, McLaughlin J, Pather S Vaccines (Basel). 2024; 12(9).

PMID: 39340021 PMC: 11435672. DOI: 10.3390/vaccines12090989.


Global prevalence and determinants associated with the acceptance of monkeypox vaccination.

Indiastari D, Fajar J, Tamara F, Runesi O, Hakim L, Chotimah K Narra J. 2024; 4(2):e866.

PMID: 39280280 PMC: 11391986. DOI: 10.52225/narra.v4i2.866.


References
1.
Lu P, Santibanez T, Williams W, Zhang J, Ding H, Bryan L . Surveillance of influenza vaccination coverage--United States, 2007-08 through 2011-12 influenza seasons. MMWR Surveill Summ. 2013; 62(4):1-28. View

2.
Stokley S, Santoli J, Willis B, Kelley V, Vargas-Rosales A, Rodewald L . Impact of vaccine shortages on immunization programs and providers. Am J Prev Med. 2004; 26(1):15-21. DOI: 10.1016/j.amepre.2003.09.010. View

3.
Brenner R, Simons-Morton B, Bhaskar B, Das A, Clemens J . Prevalence and predictors of immunization among inner-city infants: a birth cohort study. Pediatrics. 2001; 108(3):661-70. DOI: 10.1542/peds.108.3.661. View

4.
Gore P, Madhavan S, Curry D, McClung G, Castiglia M, ROSENBLUTH S . Predictors of childhood immunization completion in a rural population. Soc Sci Med. 1999; 48(8):1011-27. DOI: 10.1016/s0277-9536(98)00410-9. View

5.
Kimmel S, Burns I, Wolfe R, Zimmerman R . Addressing immunization barriers, benefits, and risks. J Fam Pract. 2007; 56(2 Suppl Vaccines):S61-9. View